Original Research
Published on 16 Oct 2020
MPL Adjuvant Contains Competitive Antagonists of Human TLR4
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2020.577823
- 22,670 views
- 83 citations
61 articles related to "Partial Agonist"
Articles
Hypothesis and Theory
Published on 02 Jul 2025
The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591763
- 3,062 views
Original Research
Published on 30 Jun 2023
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1170541
- 6,667 views
- 1 citation
Review
Published on 06 Apr 2022
Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.832209
- 9,504 views
- 25 citations
Original Research
Published on 07 Jul 2021
Ectopic Overexpression of PPARÎł2 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.683156
- 5,188 views
- 8 citations
Case Report
Published on 06 Sep 2022
Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.976387
- 3,878 views
- 9 citations
Original Research
Published on 26 Nov 2021
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
in Neurocognitive Aging and Behavior
Frontiers in Aging Neuroscience
doi 10.3389/fnagi.2021.757850
- 2,944 views
- 3 citations
Review
Published on 23 Nov 2021
Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.784370
- 11,505 views
- 14 citations
Original Research
Published on 08 Feb 2017
Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2017.00050
- 4,220 views
- 20 citations
Original Research
Published on 29 Jan 2025
Trace amine-associated receptors (TAARs)2-9 knockout mice exhibit reduced wakefulness and disrupted REM sleep
in Molecular Psychiatry
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1467964
- 2,818 views
- 1 citation
Original Research
Published on 12 May 2015
Unexpected plant odor responses in a moth pheromone system
in Invertebrate Physiology
Frontiers in Physiology
doi 10.3389/fphys.2015.00148
- 19,957 views
- 40 citations
Review
Published on 24 Mar 2022
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.785592
- 8,651 views
- 9 citations
Original Research
Published on 11 May 2022
Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.887547
- 6,347 views
- 11 citations
Mini Review
Published on 05 Mar 2018
Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2018.00070
- 5,153 views
- 7 citations
Original Research
Published on 12 Apr 2022
The Effect of the 5-HT4 Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain
in Molecular Psychiatry
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.859123
- 12,357 views
- 9 citations
Mini Review
Published on 08 Sep 2015
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00190
- 28,298 views
- 72 citations